Scatter factor/hepatocyte growth factor in brain tumor growth and angiogenesis
about
Effects of simulated altitude (normobaric hypoxia) on cardiorespiratory parameters and circulating endothelial precursors in healthy subjectsVEGF inhibits tumor cell invasion and mesenchymal transition through a MET/VEGFR2 complexRadioresistance of Brain TumorsCytokine Regulation of Microenvironmental Cells in Myeloproliferative NeoplasmsMET: a critical player in tumorigenesis and therapeutic targetTargeting the epithelial to mesenchymal transition in glioblastoma: the emerging role of MET signalingMechanisms of evasive resistance to anti-VEGF therapy in glioblastomaPhase 1 dose escalation trial of the safety and pharmacokinetics of cabozantinib concurrent with temozolomide and radiotherapy or temozolomide after radiotherapy in newly diagnosed patients with high-grade gliomas.Multiple receptor tyrosine kinases converge on microRNA-134 to control KRAS, STAT5B, and glioblastomaMicroRNA-608 and microRNA-34a regulate chordoma malignancy by targeting EGFR, Bcl-xL and MET.Cooperation between c-Met and focal adhesion kinase family members in medulloblastoma and implications for therapy.An orally bioavailable c-Met kinase inhibitor potently inhibits brain tumor malignancy and growth.microRNA-34a is tumor suppressive in brain tumors and glioma stem cells.XL-184, a MET, VEGFR-2 and RET kinase inhibitor for the treatment of thyroid cancer, glioblastoma multiforme and NSCLC.MicroRNA-34a inhibits glioblastoma growth by targeting multiple oncogenes.Transcription-dependent epidermal growth factor receptor activation by hepatocyte growth factor.Interactions between PTEN and receptor tyrosine kinase pathways and their implications for glioma therapyRegulatory mechanisms of testosterone-stimulated song in the sensorimotor nucleus HVC of female songbirds.Therapeutic strategies for inhibiting invasion in glioblastoma.Mesenchymal stem cell transition to tumor-associated fibroblasts contributes to fibrovascular network expansion and tumor progressionHepatocyte growth factor (HGF) modulates GABAergic inhibition and seizure susceptibility.Progress on antiangiogenic therapy for patients with malignant glioma.Experimental approaches for the treatment of malignant gliomas.Expression of hepatocyte growth factor and its receptor c-Met in human pituitary adenomasDevelopment of c-MET pathway inhibitors.Non-agonistic bivalent antibodies that promote c-MET degradation and inhibit tumor growth and others specific for tumor related c-MET.Inhibition of the MET Receptor Tyrosine Kinase as a Novel Therapeutic Strategy in MedulloblastomaGlial progenitors as targets for transformation in glioma.Enhanced epidermal growth factor, hepatocyte growth factor, and vascular endothelial growth factor expression in tuberous sclerosis complex.Profiling the dynamics of a human phosphorylome reveals new components in HGF/c-Met signaling.Targeting c-Met receptor overcomes TRAIL-resistance in brain tumors.The MET gene is a common integration target in avian leukosis virus subgroup J-induced chicken hemangiomas.The hepatocyte growth factor/c-Met signaling pathway as a therapeutic target to inhibit angiogenesis.The HGF inhibitory peptide HGP-1 displays promising in vitro and in vivo efficacy for targeted cancer therapy.Lessons from anti-vascular endothelial growth factor and anti-vascular endothelial growth factor receptor trials in patients with glioblastoma.Semaphorin 3A overcomes cancer hypoxia and metastatic dissemination induced by antiangiogenic treatment in miceA review of VEGF/VEGFR-targeted therapeutics for recurrent glioblastoma.Tumor-derived hepatocyte growth factor is associated with poor prognosis of patients with glioma and influences the chemosensitivity of glioma cell line to cisplatin in vitro.Expression and prognostic impact of matrix metalloproteinase-2 (MMP-2) in astrocytomas.EGFR and c-Met Cross Talk in Glioblastoma and Its Regulation by Human Cord Blood Stem Cells
P2860
Q21284409-5F1FC49C-0FA6-40B3-948F-A4BDC099A58AQ24293027-FFEA8459-18D8-4E97-AC76-738675DF8916Q26752579-2A1D30B0-F7AC-42D2-9897-191634095336Q26778929-4EBFB012-AECC-4DE9-AEC3-6AEBD7418F14Q27008925-293372DB-D529-4BE5-A7DC-9F51F9B3F253Q27011423-B3AD1BD2-E1AF-4C8B-8857-65E567EB41ADQ27021470-63638D9C-94C7-422B-BE0B-4227F84310FDQ30278053-6CE372FB-78D8-4910-94E2-4E03332073DCQ30405446-03B0E9B6-022A-4049-B3CB-B06EF382E609Q30414321-683B6007-4675-42B9-BDD0-20320C0384A5Q30422676-FA86766C-58B0-4D85-8A92-2E3FF86FD560Q30428363-E5897DD0-1A3E-4EE0-87BD-BBF392402A34Q30428366-A0DD9A49-9E50-4BA6-9CD9-2F13BF2024CBQ30428632-C387B84D-AAB9-4664-A39B-7D1F455E5C48Q30434616-79F89EDF-29D9-4B6E-91F8-05DDE83307A6Q30436756-C101D9B3-767B-4504-A184-15E0B8AA93C5Q30437740-03FFC0EA-7584-46B1-86CE-21F49F209961Q30606953-5A8514DC-49EC-48F6-ABD4-CA6E1720D444Q33426563-57770C6A-B25F-4A80-A5A7-BE3361F34206Q33427809-532B7ABD-FDE8-442F-A525-03084C1106BEQ33615358-A7F5BC48-4381-46D7-85F4-CDCC2D8E109AQ33773189-37656A5F-542D-467D-8F7E-B9F432F2C155Q34127138-A404B776-8731-4335-AA03-5FF47773CD86Q34133016-12A4ED87-C8F0-4DAC-BDE0-A80FC7D1141CQ34198905-2B50C122-A800-4F7A-B292-20A4A26BF01AQ34236834-290E1F4C-98AB-4B50-A4FA-E7BB3F8AD046Q34398276-490E73CC-2625-4FC4-951C-45B549B71B58Q34735661-F8A17BCD-9C9B-46E8-8479-71A970DE9C12Q34755802-86C18F6F-D9FA-42AE-932A-C4C9DBC6BB47Q34983997-B27178D7-CB7D-4874-8D48-C0D0ED7783ABQ35153149-59BEEA4E-CA3A-4037-84CA-9F231C11B4F9Q35488562-C4C02178-8EB7-4333-9A9F-4681B6C46653Q35563524-3F227BA8-83EC-4EFA-A450-040177A3EC3DQ35740444-6231E2C4-B477-4768-8474-4DFA8633A26FQ35895174-11AD4035-6A2B-4B9F-AAF6-E608E9149209Q35913662-2F0B3503-1893-4CD2-A2CB-593DC317D110Q36103026-B2265D02-2A35-4063-A331-2B4F23EB6596Q36249219-F9626005-91E7-46BE-BDBB-EA72CA9C548AQ36289595-85216EC6-69FB-4E35-896C-181BEF1A7600Q36310662-8D7ABD2D-1277-445A-8942-547318F49F6E
P2860
Scatter factor/hepatocyte growth factor in brain tumor growth and angiogenesis
description
2005 nî lūn-bûn
@nan
2005 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2005 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2005年の論文
@ja
2005年学术文章
@wuu
2005年学术文章
@zh-cn
2005年学术文章
@zh-hans
2005年学术文章
@zh-my
2005年学术文章
@zh-sg
2005年學術文章
@yue
name
Scatter factor/hepatocyte growth factor in brain tumor growth and angiogenesis
@ast
Scatter factor/hepatocyte growth factor in brain tumor growth and angiogenesis
@en
Scatter factor/hepatocyte growth factor in brain tumor growth and angiogenesis
@nl
type
label
Scatter factor/hepatocyte growth factor in brain tumor growth and angiogenesis
@ast
Scatter factor/hepatocyte growth factor in brain tumor growth and angiogenesis
@en
Scatter factor/hepatocyte growth factor in brain tumor growth and angiogenesis
@nl
prefLabel
Scatter factor/hepatocyte growth factor in brain tumor growth and angiogenesis
@ast
Scatter factor/hepatocyte growth factor in brain tumor growth and angiogenesis
@en
Scatter factor/hepatocyte growth factor in brain tumor growth and angiogenesis
@nl
P2860
P3181
P1433
P1476
Scatter factor/hepatocyte growth factor in brain tumor growth and angiogenesis
@en
P2093
John Laterra
Roger Abounader
P2860
P304
P3181
P356
10.1215/S1152851705000050
P407
P577
2005-10-01T00:00:00Z